Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies

Cognitive and Behavioral Neurology

Volumn 22, Issue 1, 2009, Pages 63-66

  Modoni, Anna ^a   Masciullo, Marcella ^a   Spinelli, Pietro ^a   Marra, Camillo ^a   Tartaglione, Tommaso ^a   Andreetta, Francesca ^c   Tonali, Pietro ^a,b   Silvestri, Gabriella ^b,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Autoimmune limbic encephalitis; NMDAR; VGKC

Indexed keywords

CELL ANTIBODY; ETIRACETAM; IMMUNOGLOBULIN; MEMBRANE ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENOBARBITAL; PREDNISONE; PROPOFOL; VALPROIC ACID; VOLTAGE GATED POTASSIUM CHANNEL; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONSCIOUSNESS DISORDER; CONVALESCENCE; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; GENERAL CONDITION IMPROVEMENT; GRAND MAL SEIZURE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MEMORY DISORDER; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; SCREENING TEST; SHORT COURSE THERAPY; SLOW BRAIN WAVE; TEMPORAL LOBE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS ETIOLOGY; VIRUS INFECTION; CELL MEMBRANE; DRUG ANTAGONISM; IMMUNOLOGY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; SEIZURE;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; AUTOIMMUNE DISEASES; CELL MEMBRANE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; POTASSIUM CHANNELS, VOLTAGE-GATED; PREDNISONE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

EID: 67049107961     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e318190d195     Document Type: Article

References (12)

1. Tü zü n E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261-271. (Pubitemid 47396312)
2. Vernino S, Geschwind M, Boeve B. Autoimmune encephalopathies. Neurologist. 2007;13:140-147. (Pubitemid 46743081)
3. Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380-386. (Pubitemid 43923159)
4. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain. 2004;127:701-712. (Pubitemid 38295483)
5. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177-1182.
6. Dalmau J, Tü zü n E, Wu HY, et al. Paraneoplastic anti-N-methyl- D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36. (Pubitemid 46214241)
7. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504-511. (Pubitemid 351653374)
8. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764-1777. (Pubitemid 41373648)
9. Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78:381-385. (Pubitemid 46580546)
10. Samarasekera SR, Vincent A, Welch JL, et al. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry. 2007;78: 391-394. (Pubitemid 46580548)
11. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol. 1996;36: 378-384. (Pubitemid 26343685)
12. Illa I. IVIg in myastheian gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. J Neurol. 2005;252(suppl 1):I14-I18.